Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

JYSSBio Closes B+ Round for Single-Use Bioreactor Manufacturing

publication date: Jan 17, 2022

Zhejiang JYSS Bio-Engineering closed a B+ round led by Huatai International Private Equity Fund to expand its single use bioreactor and assemblies manufacturing. In 2014, JYSSBio was the first China company to offer single use bioreactors. In 2018, the company began large-scale manufacturing and entered the CDMO business. JYSSBio said it would use the proceeds to increase its manufacturing capacity expansion and make further R&D investments. The size of the financing was not disclosed. Mpre details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio Event
Beijing and Digital
September 13-16, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022